Browsing Tag
Milestone Pharmaceuticals Inc
1 post
Milestone Pharmaceuticals (NASDAQ: MIST) gets FDA green light for etripamil nasal spray
Discover how Milestone Pharmaceuticals’ FDA approval of CARDAMYST (etripamil) is reshaping PSVT treatment and setting the stage for broader cardiovascular care. Read more.